Florian Kreuzer
Principal, Head of DACH
Florian is Head of DACH and focuses on investment opportunities in the DACH region and in Healthcare globally. He has worked on a number of transactions including Neuraxpharm and Ergomed. He is a member of the advisory board of Neuraxpharm and CABB as well as a member of the board of directors of Ergomed.
Prior to joining Permira, Florian worked for more than 13 years at The Carlyle Group, where he was a Director in the European Buyout Team based in London. He focused on large buyout transactions in the DACH and Benelux regions and was responsible for various investments in the healthcare, industrials and consumer goods industries.
Prior to joining Permira, Florian worked for more than 13 years at The Carlyle Group, where he was a Director in the European Buyout Team based in London. He focused on large buyout transactions in the DACH and Benelux regions and was responsible for various investments in the healthcare, industrials and consumer goods industries.
Qualifications
Florian holds a Master’s degree in Business Administration and Economics from WHU Otto Beisheim School of Management, Germany and has an MBA from McCombs School of Business at the University of Texas, USA.
Office
Permira Beteiligungsberatung GmbH
Bockenheimer Landstrasse 33
60325 Frankfurt am Main
Bockenheimer Landstrasse 33
60325 Frankfurt am Main
